| Filed On | Filing |
|---|---|
| 26 Oct 2026 |
8-K: Termination of a Material Definitive Agreement
On October 20, 2026, Supernus Pharmaceuticals, Inc. (the “Company”) terminated the UBS Credit Line Agreement, dated as of February 8, 2023 (the “UBS Credit Line”), between the Company and UBS Bank USA (the “Bank”), which established an u... |
| 22 Oct 2026 |
8-K: Other Events
Orphan-drug exclusivity provides seven years of market exclusivity for ONAPGO |
| 19 Oct 2026 |
8-K: Results of Operations and Financial Condition
ROCKVILLE, Md., October 19, 2026 – Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced ... |
| 15 Oct 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On October 15, 2026 Supernus Pharmaceuticals, Inc. (the “Company”) held a special meeting of its stockholders (the “Special Meeting”). The definitive proxy statement pertaining to the Special Meeting was previously filed by the Company w... |
| 03 Aug 2026 | 8-K: Other Events |
| 03 Aug 2026 | 8-K: Other Events |
| 03 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 03 Aug 2026 | 8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more |
| 22 Jul 2026 | 8-K: Results of Operations and Financial Condition |
| 18 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 20 May 2026 | 8-K: Creation of a Direct Financial Obligation |
| 05 May 2026 | 8-K: Results of Operations and Financial Condition |
| 22 Apr 2026 | 8-K: Results of Operations and Financial Condition |
| 07 Apr 2026 | 8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets |
| 24 Feb 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 24 Feb 2026 | 8-K: Results of Operations and Financial Condition |
| 12 Feb 2026 | 8-K: Results of Operations and Financial Condition |
| 28 Jan 2026 | 8-K: Financial Statements and Exhibits |
| 04 Nov 2025 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 21 Oct 2025 | 8-K: Results of Operations and Financial Condition |
Loading...
